Dr Hans-Georg Feldmeier holds the position of CEO at Dermapharm. He joined the company in 2003 as the manager responsible for setting up production in Sandersdorf-Brehna. He has been Dermapharm’s Chief Production & Development Officer since 2009. Dr Feldmeier began his professional career in 1987 at Berlin-Chemie AG. As Head of Production and Technology, he was instrumental in modernising the company after the fall of the Berlin Wall. In 2002, he was Head of the Supply Centre at Schering Aktiengesellschaft, Berlin.

Dr. Andreas Eberhorn has been responsible for marketing and sales at Dermapharm as Chief Marketing Officer since 1 September 2022. He holds a doctorate in biology and has many years of experience in the pharmaceutical industry. From 2014 to 2018, he was already responsible for the specialty business as a member of the Management Board of Hexal AG. Since 2018, he has been Country Head at Sandoz Austria and most recently Head of Retail Cluster II (Rx and OTC) for the European region at Sandoz.

MBA (International General Management), MAS (Public Health), has been responsible for the international business of the Dermapharm Group since 2024. He has many years of experience in various areas of the pharmaceutical industry and most recently served as Vice President and Managing Director for medium-sized companies in the European region.